首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2940795篇
  免费   216699篇
  国内免费   4882篇
耳鼻咽喉   41720篇
儿科学   92859篇
妇产科学   80253篇
基础医学   432005篇
口腔科学   82437篇
临床医学   264250篇
内科学   563664篇
皮肤病学   63848篇
神经病学   233424篇
特种医学   111694篇
外国民族医学   653篇
外科学   446238篇
综合类   66438篇
现状与发展   13篇
一般理论   1053篇
预防医学   230720篇
眼科学   69578篇
药学   219363篇
  11篇
中国医学   5808篇
肿瘤学   156347篇
  2018年   31738篇
  2017年   24099篇
  2016年   26878篇
  2015年   30519篇
  2014年   43274篇
  2013年   65198篇
  2012年   89462篇
  2011年   95000篇
  2010年   56315篇
  2009年   53145篇
  2008年   89459篇
  2007年   95692篇
  2006年   96284篇
  2005年   93707篇
  2004年   90162篇
  2003年   86925篇
  2002年   84072篇
  2001年   130142篇
  2000年   133413篇
  1999年   112437篇
  1998年   33201篇
  1997年   29375篇
  1996年   29453篇
  1995年   27797篇
  1994年   25829篇
  1993年   24338篇
  1992年   88778篇
  1991年   86926篇
  1990年   85010篇
  1989年   81881篇
  1988年   75711篇
  1987年   74237篇
  1986年   69736篇
  1985年   67168篇
  1984年   50596篇
  1983年   43157篇
  1982年   26136篇
  1981年   23677篇
  1979年   47863篇
  1978年   34328篇
  1977年   28621篇
  1976年   27260篇
  1975年   29392篇
  1974年   35656篇
  1973年   33959篇
  1972年   32067篇
  1971年   30160篇
  1970年   28097篇
  1969年   27014篇
  1968年   24600篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
芦荟自古就被用作化妆品和药物添加剂,近来更受喜爱。虽应用广泛,但过敏反应罕有报道。作者用芦荟叶的油性提取物、来自整个植株的芦荟粉及浓缩的芦荟凝胶,对相继就诊的702例患者做斑贴试验。设计专门的问卷调查芦荟的使用、使用原因、使用部位、不良反应、患者职业、个人爱好及是否为遗传性过敏体质。患者均未对任一制剂发生任何反应。需对芦荟所含的两种成分加以鉴别:即芦荟叶皮含有的具有促进肠蠕动、潜在抗菌及抗癌特性的蒽醌类物质。  相似文献   
92.
The absence of the temporary incisors could be to a genetic illness or to some multiple premature extractions. These extractions are the aftermaths of the carious lesions or some traumatisms underwent by the temporary incisors. Beyond measure the loss of the space, the premature loss some temporary incisors very often assign the relational development of the child and disturb its psychological development and the aesthetic function. Across some cases clinics, the authors show that the replacement of the temporary incisors is the therapeutic ideal solution. Indeed, the child prosthesis, replacing the temporary absent incisors, solves the psychological, aesthetic and relational problems of the child.  相似文献   
93.
94.
背景:针对糖尿病患者Lp(a)水平和冠状动脉疾病(CAD)严重程度之间关系的研究较少并且结论有争议。另外,目前尚无关于apo(a)多态性与上述疾病关系的研究。本研究旨在探讨大样本2型糖尿病患者中冠状动脉粥样硬化的程度与Lp(a)水平及apo(a)多态性的相关性。方法:连续选取227例2型糖  相似文献   
95.
96.
Continual loading and articulation cycles undergone by metallic (e.g., titanium) alloy arthroplasty prostheses lead to liberation of a large number of metallic debris particulates, which have long been implicated as a primary cause of periprosthetic osteolysis and postarthroplasty aseptic implant loosening. Long-term stability of total joint replacement prostheses relies on proper integration between implant biomaterial and osseous tissue, and factors that interfere with this integration are likely to cause osteolysis. Because multipotent mesenchymal stem cells (MSCs) located adjacent to the implant have an osteoprogenitor function and are critical contributors to osseous tissue integrity, when their functions or activities are compromised, osteolysis will most likely occur. To date, it is not certain or sufficiently confirmed whether MSCs endocytose titanium particles, and if so, whether particulate endocytosis has any effect on cellular responses to wear debris. This study seeks to clarify the phenomenon of titanium endocytosis by human MSCs (hMSCs), and investigates the influence of endocytosis on their activities. hMSCs incubated with commercially pure titanium particles exhibited internalized particles, as observed by scanning electron microscopy and confocal laser scanning microscopy, with time-dependent reduction in the number of extracellular particles. Particulate endocytosis was associated with reduced rates of cellular proliferation and cell-substrate adhesion, suppressed osteogenic differentiation, and increased rate of apoptosis. These cellular effects of exposure to titanium particles were reduced when endocytosis was inhibited by treatment with cytochalasin D, and no significant effect was seen when hMSCs were treated only with conditioned medium obtained from particulate-treated cells. These findings strongly suggest that the biological responses of hMSCs to wear debris are triggered primarily by the direct endocytosis of titanium particulates, and not mediated by secreted soluble factors. In this manner, therapeutical approaches that suppress particle endocytosis could reduce the bioreactivity of hMSCs to particulates, and enhance long-term orthopedic implant prognosis by minimizing wear-debris periprosthethic osteolysis.  相似文献   
97.
Genomes of some parasites contain dozens of alternative and highly diverged surface antigens, of which only a single one is expressed in any cell. Individual cells occasionally change expression of their surface antigen, allowing them to escape immune surveillance. These switches appear to occur in a partly random way, creating a diverse set of antigenic variants. In spite of this diversity, the parasitemia develops as a series of outbreaks, in which each outbreak is dominated by relatively few antigenic types. Host-specific immunity eventually clears the dominant antigenic types, and a new outbreak follows from antigenic types that have apparently been present all along at low frequency. This pattern of sequential dominance by different antigenic types remains unexplained. We review the five most prominent theories, which have developed mainly from studies of the protozoans Trypanosoma and Plasmodium, and the bacterial spirochete Borrelia. The most promising theories depend on some combination of mechanisms to create favored connectivity pathways through the matrix of transitions between variants. Favored pathways may arise from biased switches at the molecular level of gene expression or from biases imposed by immune selection. We illustrate the concept of connectivity pathways by reanalysis of data on transitions between variants from Borrelia hermsii.  相似文献   
98.
99.
100.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号